Republican control of the House will transform the agenda for oversight of the biopharma-related policy issues, with the Centers for Medicare & Medicaid Services likely to face more pressure than FDA.
Major media outlets have now declared Republicans the winner in 219 of the House races, enough to secure the majority...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?